Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 28
2003 25
2004 28
2005 35
2006 24
2007 9
2008 26
2009 14
2010 24
2011 27
2012 28
2013 32
2014 43
2015 44
2016 44
2017 41
2018 60
2019 45
2020 65
2021 62
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

630 results
Results by year
Filters applied: . Clear all
Page 1
Monoclonal Immunoglobulin Deposition Disease and Related Diseases.
Kanzaki G, Okabayashi Y, Nagahama K, Ohashi R, Tsuboi N, Yokoo T, Shimizu A. Kanzaki G, et al. Among authors: shimizu a. J Nippon Med Sch. 2019;86(1):2-9. doi: 10.1272/jnms.JNMS.2019_86-1. J Nippon Med Sch. 2019. PMID: 30918151 Free article. Review.
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S. Toi M, et al. Among authors: shimizu a. Lancet Oncol. 2021 Jan;22(1):74-84. doi: 10.1016/S1470-2045(20)30534-9. Lancet Oncol. 2021. PMID: 33387497 Clinical Trial.
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties.
Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, Shand FHW, Komohara Y, Takeda M, Kokubo K, Chen MC, Yokoi S, Rokutan H, Kofuku Y, Ohnishi K, Ohira M, Iizasa T, Nakano H, Okabe T, Kojima H, Shimizu A, Kanegasaki S, Zhang MR, Shimada I, Nagase H, Terasawa H, Matsushima K. Terashima Y, et al. Among authors: shimizu a. Nat Commun. 2020 Jan 30;11(1):609. doi: 10.1038/s41467-020-14338-5. Nat Commun. 2020. PMID: 32001710 Free PMC article.
Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
Sugahara M, Tanaka S, Tanaka T, Saito H, Ishimoto Y, Wakashima T, Ueda M, Fukui K, Shimizu A, Inagi R, Yamauchi T, Kadowaki T, Nangaku M. Sugahara M, et al. Among authors: shimizu a. J Am Soc Nephrol. 2020 Mar;31(3):560-577. doi: 10.1681/ASN.2019060582. Epub 2020 Jan 29. J Am Soc Nephrol. 2020. PMID: 31996409 Free PMC article.
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I. Hamanishi J, et al. Among authors: shimizu a. J Clin Oncol. 2015 Dec 1;33(34):4015-22. doi: 10.1200/JCO.2015.62.3397. Epub 2015 Sep 8. J Clin Oncol. 2015. PMID: 26351349 Clinical Trial.
The Renal Pathology of Obesity.
Tsuboi N, Okabayashi Y, Shimizu A, Yokoo T. Tsuboi N, et al. Among authors: shimizu a. Kidney Int Rep. 2017 Jan 23;2(2):251-260. doi: 10.1016/j.ekir.2017.01.007. eCollection 2017 Mar. Kidney Int Rep. 2017. PMID: 29142961 Free PMC article. Review.
Human nephron number, hypertension, and renal pathology.
Kanzaki G, Tsuboi N, Shimizu A, Yokoo T. Kanzaki G, et al. Among authors: shimizu a. Anat Rec (Hoboken). 2020 Oct;303(10):2537-2543. doi: 10.1002/ar.24302. Epub 2019 Nov 15. Anat Rec (Hoboken). 2020. PMID: 31729838 Free article. Review.
630 results